Current management of hepatitis C in New Zealand.

نویسنده

  • E Gane
چکیده

page – this must not exceed 200 words and should describe the core of the paper’s message, including essential numerical data. Use four headings: Aims, Methods, Results, Conclusions. Body of the paper – there should be a brief introduction (no heading) followed by sections for Methods, Results, Discussion, Acknowledgements and Correspondence. References – in the text use superscript numbers for each reference. Titles of journals are abbreviated according to the style used by Index Medicus for articles in journals the format is: Braatvedt GD. Outcome of managing impotence in clinical practice. NZ Med J 1999; 112: 272-4. For book chapters the format is: Marks P. Hypertension. In: Baker J, editor. Cardiovascular disease. 3rd ed. Oxford: Oxford University Press; 1998. p567-95. Note all authors Addresses Editorial: All editorial correspondence is sent to Professor Nicholls, c/o Department of Medicine, Christchurch Hospital, PO Box 4345 Christchurch, New Zealand. Telephone (03) 364 1116; Facsimile (03) 364 1115; email [email protected] Advertising: All correspondence is to be sent to the Advertising Manager, Print Advertising, 83-91 Captain Springs Road, PO Box 13 128 Onehunga, Auckland. Telephone (09) 634-4982; Facsimile (09) 634-4951; email [email protected] or PO Box 27194, Upper Willis Street, Wellington. Telephone (04) 801-6187; Facsimile (04) 801-6261; email [email protected] Circulation: All correspondence about circulation, subscriptions, change of address and missing numbers is sent to Chief Executive Officer, New Zealand Medical Association, PO Box 156, Wellington. Telephone (04) 472-4741; Facsimile (04) 471-0838. email [email protected] Publisher: The Journal is published by Southern Colour Print, PO Box 920, Dunedin. Telephone (03) 455-0554; Facsimile (03) 455-0303. Subscriptions: New Zealand – standard mail NZ$255.15, fastpost NZ$272.25 (GST incl); overseas surface mail NZ$280.00, overseas airmail – South Pacific/Australia NZ$340.00; America/Asia/India/Europe NZ$420.00; Africa/ Middle East NZ$490.00. All subscription enquiries to NZ Medical Association, as for Circulation above. Twice monthly except December & January Copyright New Zealand Medical Association ISSN 0028 8446 Established 1887 Journal of the New Zealand Medical Association THE NEW ZEALAND MEDICAL JOURNAL

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Triethylenetetramine reduces some blood parameters in alloxan-induced diabetes mellitus in New Zealand white rabbit: evidence for histopathologic effects

This study aimed to assess whether the triethylenetetramine (TETA) is impressed the plasma level of homocysteine (Hcy), total sialic acid (TSA) and cardiac troponin I (cTnI) as cardiovascular diseases risk factors, cystatin c (Cys c) and glucose along with histopathologic changes in alloxan induced diabetes mellitus in rabbit. Twenty number New Zealand white rabbits were assigned for this study...

متن کامل

Decentralisation of Health Services in Fiji: A Decision Space Analysis

Background Decentralisation aims to bring services closer to the community and has been advocated in the health sector to improve quality, access and equity, and to empower local agencies, increase innovation and efficiency and bring healthcare and decision-making as close as possible to where people live and work. Fiji has attempted two approaches to decentralisation. The current approach refl...

متن کامل

Hepatitis C Virus and Vaccine Development

The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generating new vaccines or drugs is an obligation. However, there is no vaccine available for clinical u...

متن کامل

“Sell an Ox” - The Price of Cure for Hepatitis C in Two Countries

Chronic hepatitis C virus (HCV) infection, associated with severe liver disease and cancer, affects 70 million people worldwide. New treatments with direct-acting-antivirals offer cure for about 95% of affected individuals; however, treatment costs may be prohibitive in both the poorest and richest nations. Opting for cure may require sacrificing essential household ass...

متن کامل

Prevalence and epidemiology of hepatitis C virus (HCV) infection in Rafsanjan

Abstract Background: Many individuals with chronic hepatitis C virus (HCV) infection are asymptomatic, population-based serologic studies are needed to estimate the prevalence of  infection which will help to take necessary procedures for prevension and control the disease.This study was conducted to find out the prevalence, of HCV infection among patients refering to the  hospit...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • The New Zealand medical journal

دوره 114 1128  شماره 

صفحات  -

تاریخ انتشار 2001